Two decades of light-touch oversight are ending. Here’s the intelligence retailers and brands need before the shelf resets.
It started with an audit.
In the spring of 2021, Canada’s federal auditors pulled back the curtain on the natural health products industry and found a system running largely on trust. Health Canada was approving products on paper but rarely inspecting the sites that manufactured them. When auditors examined a sample of licensed products, 88% carried potentially misleading claims. And on the rare occasion a genuinely unsafe product reached the shelf, the regulator had no power to pull it — it could not order a recall.
That report lit a fuse. Five years on, its findings have hardened into the most consequential regulatory overhaul the Canadian supplement industry has seen since the Natural Health Products Regulations first took effect in 2004. For retailers and brands, 2026 is the year it stops being a policy debate in Ottawa and starts rearranging what sits on the shelf.
The stakes are not small. Roughly 77% of Canadians reach for natural health products regularly, and the market they support is worth about $2.8 billion and climbing near 7.6% a year. A category that large, that trusted, and that lightly policed was never going to stay untouched once the auditors had spoken. Three changes now carry the response — and each one lands on a different line of the balance sheet.
Teeth: how $5 million changes the math
The first and bluntest change is enforcement. Folded into the federal government’s 2023 budget bill, Bill C-47 stripped natural health products of their long-standing exemption from the Protecting Canadians from Unsafe Drugs Act — Vanessa’s Law. Much of the industry, by its own account, was caught off guard.
The effect is a regulator with real leverage for the first time. Health Canada can now order a recall, compel a company to change a label or its packaging, demand internal records, and levy penalties for serious violations of up to $5 million. Under the old regime, the ceiling sat in the low thousands.
That is not a tougher edition of the same rulebook. It is a different order of risk. For a brand that once filed a borderline claim under “cost of doing business,” the downside just grew by three orders of magnitude — and moved from the back office to the risk register.
The label becomes the battleground
If Vanessa’s Law is the stick, the new labelling regime is the daily grind. Since 21 June 2025, natural health products must carry a standardized “Product Facts” table — plain-language, bilingual, set in a minimum type size — modelled on the panels Canadians already read on over-the-counter medicines. It is a direct answer to that 88% misleading-claims finding: make every label legible, comparable, and honest.
Products licensed before that date get a three-year runway, so the whole market must comply by 21 June 2028. On the surface it reads like a design refresh. On the ground it is a capital decision taken one SKU at a time. Relabelling costs real money, and for a slow mover the numbers often will not justify the reprint. The likeliest casualties are the small, differentiated lines — the artisanal tinctures and single-origin botanicals that give an independent store its character and, frequently, its fattest margins. Many of those products won’t be reformulated or redesigned. They’ll simply disappear.
Who pays to be regulated
The third change still hangs over the industry: cost recovery. Health Canada has proposed billing the sector for the cost of overseeing it — a $317 annual right-to-sell fee for every natural product number, a site licence fee near $4,784, and pre-market evaluation fees from roughly $1,100 to more than $58,000, softened by remissions for qualifying small businesses.
For now the plan is paused, parked while the wider modernization framework is settled. But paused is not repealed. When the fees return — and Health Canada has signalled they will — they reprice a company’s entire catalogue at a stroke. A flat per-product charge is a rounding error for a national brand spreading it across millions in sales; for a small supplier with a long tail of niche NPNs, it can push a whole shelf underwater overnight. The operators running that math today are the ones who will still be trading when the invoice arrives.
The industry pushes back
None of this has happened quietly. The Canadian Health Food Association’s “Save Our Supplements” campaign has become one of the most visible advocacy pushes the sector has ever mounted — more than 100,000 petition signatures and over a million postcards sent to MPs, Health Canada and the Prime Minister’s Office. Its argument isn’t that the industry opposes safety, but that the cost and complexity of the new regime will thin choice and lift prices for the 77% of Canadians who count on these products.
That tension — consumer protection on one side, access and affordability on the other — is the real story beneath the regulations, and it is far from resolved. The pause on cost recovery is evidence the pressure is landing. Retailers and brands who read that politics will forecast the next 18 months far more accurately than those treating the rules as fixed.
What it means on the floor
Strip away the policy language and the message for retailers is plain: your shelf sits downstream of all of it. Recall and liability exposure now travel with the products you carry, which turns supplier due diligence into part of buying rather than a formality — asking for compliance attestations is no longer overcautious. The 2028 deadline and the eventual return of fees will thin the supplier base from the bottom up, and the products most exposed are exactly the high-margin, hard-to-replace lines you can least afford to lose. The retailers who come out ahead will flag their at-risk SKUs early and start the supplier conversations now, well before the delisting notices land.
For brands and their marketers, the calculus has flipped. Compliance used to be overhead; in this market it is a moat. A clean regulatory file, genuine substantiation behind every claim, and demonstrable retail velocity are increasingly what buyers reward and acquirers pay up for. Marketing teams carry the sharpest new exposure of all: under Vanessa’s Law, an unsupported claim is no longer a ticket but a seven-figure liability. The discipline that wins is claims that sell and survive an audit — every assertion mapped to its evidence before it reaches a label, a landing page, or a shelf-talker.
The year to get ahead of it
For all the unease, none of this shrinks the prize. Canadians are buying more natural health products, not fewer, and demand across supplements, functional foods and condition-specific formulas keeps rising. What’s changing is the barrier to entry — and, with it, who gets to compete. Tighter rules reward scale, discipline and evidence; they punish the casual operator. That is uncomfortable for parts of the industry and a real advantage for the businesses ready to meet the moment.
The rules arriving through 2026 aren’t a storm to wait out. They’re a filter. The retailers and brands treating this as a planning year — auditing assortments, pressure-testing claims, modelling the cost of what’s coming — will find the reshuffle tilting their way. The rest will spend 2028 reacting.
Frequently asked questions
Why is Canada changing its natural health product rules?
A 2021 federal audit found Health Canada’s oversight fell short: it rarely inspected manufacturing sites, 88% of reviewed products carried potentially misleading claims, and the regulator had no power to order a recall. The 2026 changes are the government’s response to those findings.
Does Vanessa’s Law apply to natural health products in Canada?
Yes. Bill C-47 (Royal Assent, June 2023) removed the NHP exemption, giving Health Canada authority to order recalls, mandate label and packaging changes, compel records, and impose penalties of up to $5 million for serious non-compliance.
When do the new NHP labelling rules take effect?
The improved-labelling provisions came into force on 21 June 2025. Products licensed before that date have a three-year transition, so all NHP labels must comply by 21 June 2028.
What are the proposed NHP cost-recovery fees?
The proposed schedule includes a $317 annual right-to-sell fee per NPN, a site licence fee of about $4,784, and pre-market evaluation fees up to $58,332, with remissions for qualifying small businesses. Implementation is currently paused.
What should retailers do now?
Ask suppliers how they are handling the 2025 labelling requirements and Vanessa’s Law compliance, identify at-risk SKUs in your assortment, and plan changes ahead of the 2028 deadline.
